Clinical Trials Browser

Phase 2 × Not yet recruiting × Mesothelioma × Clear all

NCT07514793 2026-04-07

Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma

Phase 2 Not yet recruiting

Other solid neoplasmThoracic

Mesothelioma